The growing popularity of GLP-1 weight-loss medications is transforming more than just Americans’ health.
Retailers across the United States are reporting changes in clothing sales, sizing trends and return rates as consumers lose weight, consequently replacing their wardrobes.
Drugs such as Ozempic, Wegovy and Zepbound have become increasingly common in recent years. While Ozempic is primarily approved for Type 2 diabetes, Wegovy and Zepbound are specifically prescribed for weight management. These medications work by mimicking hormones that regulate appetite and blood sugar, helping users feel full longer and consume fewer calories. As these drugs become more accessible and available due to declining prices, millions of Americans are turning to GLP-1 medications as part of their weight-loss journeys.
This trend is coming at a time when weight loss has become a major focus in American culture, fueled by social media, celebrity endorsements and increasing awareness of obesity-related health concerns. As a result, many consumers are rapidly changing clothing sizes, sometimes several times within a single year.
According to a recent Wall Street Journal report, retailers are experiencing a surge in returns as shoppers purchase multiple sizes of the same item and return those that no longer fit. Some retailers report that weight loss is becoming an increasingly common reason for apparel returns and exchanges.
The increase in returns creates high costs for retailers. Returned items often require additional shipping, labor and warehouse processing, and seasonal products may need to be discounted before being resold. Industry analysts estimate that even small increases in return rates can cost large retailers millions of dollars annually.
Retailers are also adjusting their inventories. Macy’s recently reported declining demand for plus-size apparel, while other brands have increased orders of smaller clothing sizes and updated sizing guides to reduce costly returns. Victoria’s Secret, for example, is now selling smaller bra and underwear sizes to keep up with the changing demand.
As GLP-1 medications continue to grow in popularity, their influence will likely extend beyond healthcare; it may reshape the fashion industry and force retailers to adapt to a changing consumer base.
